DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH
Delisted
DCPH was delisted on the 10th of June, 2024.
59 hedge funds and large institutions have $355M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 21 closing their positions.
Holders
59
Holders Change
+10
Holders Change %
+20.41%
% of All Funds
1.34%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
31
Increased
14
Reduced
9
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$26.7M |
| 2 |
2
BlackRock
New York
|
$8.24M |
| 3 |
PC
3
Polar Capital
London,
United Kingdom
|
$5.67M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$3.97M |
| 5 |
SFM
5
Sphera Funds Management
Tel Aviv,
Israel
|
$5.01M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FMA
76
FNY Managed Accounts
New York
| – | – | -8,100 | Closed |
|
77
SG Americas Securities
New York
| – | – | -7,544 | Closed |
|
|
PCM
78
Prelude Capital Management
New York
| – | – | -1,613 | Closed |
|
79
Credit Agricole
Montrouge Cedex,
France
| – | – | -1,000 | Closed |
|
|
CCA
80
Catalyst Capital Advisors
Huntington,
New York
| – | – | -305 | Closed |
|
|
MIM
81
Monashee Investment Management
Boston,
Massachusetts
| – | – | – | – |
|